| ACTC1 | SCN5A | COX15 | GYG1 | MYZAP | SPEG | CBL* | LDB3* | PKP4* | WISP1* |
| BAG3 | TNNC1 | COX6B1 | GYS1 | NAA10 | SURF1 | CDC25B* | LEMD2* | PPP1CB* | XK* |
| DES | TNNI3 | CRYAB | HCN4 | NDUFB11 | TAZ | CDH2* | LMOD2* | PPP1R13L* | |
| DMD | TNNT2 | CSRP3 | HFE | NF1 | TBX5 | CHRM2* | LRRC10* | PSEN1* | |
| DSC2 | TPM1 | CTNNA3 | HRAS | NRAS | TBX20 | COL7A1* | MEF2C* | PSEN2* | |
| DSG2 | TRIM63 | DLD | JPH2 | PCCA | TCAP | CTF1* | MIB1* | RBM24* | |
| DSP | TTN | DNAJC19 | KCNJ2 | PCCB | TMEM43 | CTNNA1* | MYH6* | RRAS* | |
| EMD | TTR | DOLK | KLHL24 | PLEKHM2 | TMEM70 | CTNNB1* | MYLK2* | SGCA* | |
| FHL1 | AARS2 | DTNA | KLF5 | PMM2 | TNNI3K | DNM1L* | MYLK3* | SGCB* | |
| FHOD3 | ACAD9 | DYSF | KRAS | PPA2 | VARS2 | ELAC2* | MYOM1* | SLC25A4* | |
| FLNC | ACADVL | EYA4 | LAMA2 | PPCS | ZBTB17 | FBXO32* | NEBL* | SOS2* | |
| GLA | ACTA1 | FAH | LIAS | PRDM16 | ABCC9* | FXN* | NEXN* | SPRED1* | |
| JUP | ACTN2 | FHL2 | LZTR1 | QRSL1 | AKT1* | FOXD4* | NNT* | SYNE1* | |
| LAMP2 | AGK | FKRP | MAP2K1 | RAF1 | ANK2* | GATAD1* | NONO | SYNE2* | |
| LMNA | AGL | FKTN | MAP2K2 | RIT1 | ANKRD1* | GSK3B* | NRAP* | TGFB3* | |
| MYBPC3 | AGPAT2 | FNIP1 | MLYCD | RPL3L | ATP5F1E* | HAND1* | NUBPL* | TJP1* | |
| MYH7 | ALMS1 | FOXRED1 | MRAS | RYR2 | BRAF* | HAND2* | OBSCN | TLL2* | |
| MYL2 | ALPK3 | GAA | MRPL3 | SCO2 | BSCL2* | IDH2* | P2RX7* | TMOD1* | |
| MYL3 | ANO5 | GATA4 | MRPL44 | SDHA | C10orf71* | ILK* | PDHA1* | TOR1AIP1* | |
| NKX2-5 | ASNA1 | GATA5 | MRPS22 | SGCD | CACNA1C* | ISL1* | PDLIM3* | TP63* | |
| PKP2 | ATPAF2 | GATA6 | MTO1 | SGCG | CALR* | JARID2* | PDLIM5* | TRIM54* | |
| PLN | CAV3 | GFM1 | MYBPHL | SHOC2 | CALR3* | KAT2B* | PERP* | TSFM* | |
| PRKAG2 | COA5 | GLB1 | MYOT | SLC22A5 | CASQ2* | KCNJ8* | PHKA1* | TUFM* | |
| PTPN11 | COA6 | GNPTAB | MYOZ2 | SLC25A3 | CASZ1* | KLF10* | PHKB* | TXNRD2* | |
| RBM20 | COQ2 | GUSB | MYPN | SOS1 | CAVIN4* | LAMA4* | PKD2* | VCL* | |
Genes prioritários: Genes onde há evidências suficientes (clínicas e funcionais) a serem consideradas associadas à doença; estão incluídos nas diretrizes de prática clínica.
*Genes candidatos: Evidências insuficientes em humanos, mas potencialmente associadas à doença.
Copyright ©2021 GENELAB by ABC.
Centro de Arbitragem de Conflitos de Consumo do Algarve
MADE WITH ♥ BY ALGARDATA
Copyright ©2021 GENELAB by ABC
MADE WITH ♥ BY ALGARDATA